| Epigenetic control of mitochondrial fission enables self-renewal of stem-like tumor cells in human prostate cancer G Civenni, R Bosotti, A Timpanaro, R Vazquez, J Merulla, S Pandit, ... Cell metabolism 30 (2), 303-318. e6, 2019 | 90 | 2019 |
| The mannose 6-phosphate receptor targeted with porphyrin-based periodic mesoporous organosilica nanoparticles for rhabdomyosarcoma theranostics M Daurat, C Nguyen, SD Gil, V Sol, V Chaleix, C Charnay, L Raehm, ... Biomaterials science 8 (13), 3678-3684, 2020 | 14 | 2020 |
| Surfaceome profiling of cell lines and patient-derived xenografts confirm FGFR4, NCAM1, CD276, and highlight AGRL2, JAM3, and L1CAM as surface targets for Rhabdomyosarcoma A Timpanaro, C Piccand, AC Uldry, PK Bode, D Dzhumashev, R Sala, ... International journal of molecular sciences 24 (3), 2601, 2023 | 8 | 2023 |
| CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models A Timpanaro, C Piccand, D Dzhumashev, S Anton-Joseph, A Robbi, ... Journal of Experimental & Clinical Cancer Research 42 (1), 293, 2023 | 5 | 2023 |
| Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells D Dzhumashev, S Anton-Joseph, VJ Morel, A Timpanaro, G Bordon, ... European Journal of Pharmaceutics and Biopharmaceutics 194, 49-61, 2024 | 4 | 2024 |
| Quantum Dot-based screening identifies F3 peptide and reveals cell surface nucleolin as a therapeutic target for rhabdomyosarcoma D Dzhumashev, A Timpanaro, S Ali, AJ De Micheli, K Mamchaoui, ... Cancers 14 (20), 5048, 2022 | 4 | 2022 |
| Targeted therapies for rhabdomyosarcoma M Bernasconi, D Dzhumashev, A Timpanaro, J Rössler Schweizer Krebsbulletin 2019 (39), 129-133, 2019 | 3 | 2019 |
| CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials R Ronsley, KC Bertrand, EZ Song, A Timpanaro, M Choe, D Tlais, ... Cancer and Metastasis Reviews 43 (4), 1205-1216, 2024 | | 2024 |
| DIPG-11. PRECLINICAL EFFICACY OF B7-H3 CAR T CELLS IN COMBINATION WITH ONC206 A Timpanaro, E Song, MC Biery, D Lau, M Meechan, L Elena-Sanchez, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
| Improvement of CAR T cell potency against low-density targets like L1CAM and FGFR4 in rhabdomyosarcoma C Piccand, A Timpanaro, S Anton-Joseph, M Bernasconi, JK Rössler Cancer Research 84 (6_Supplement), 4015-4015, 2024 | | 2024 |
| CAR T cells recognizing CD276 and Dual-CAR T cells against CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models A Timpanaro, C Piccand, D Dzhumashev, S Anton-Joseph, A Robbi, ... bioRxiv, 2023.09. 05.555125, 2023 | | 2023 |
| IMMU-13. PRECLINICAL EFFICACY OF MULTI-ANTIGEN (HER2/EGFR806/B7-H3/IL13RA2) TARGETING QUAD-CAR T CELLS AGAINST DIFFUSE MIDLINE GLIOMA C Myers, A Timpanaro, E Song, M Meechan, A Chen, M Biery, A Reid, ... Neuro-Oncology 25 (Suppl 1), i52, 2023 | | 2023 |
| Porphyrin-Based Mesoporous Organosilica Nanoparticles for Two-Photon Rhabdomyosarcoma Targeting M DAURAT, C NGUYEN, SD GIL, SOL Vincent, V CHALEIX, C CHARNAY, ... Photodiagnosis and Photodynamic Therapy 41, 103477, 2023 | | 2023 |
| Epigenetic reprogramming and mitochondrial dynamics drive self-renewal and tumorigenic capability of prostate cancer stem cells: new prospects for treatment of prostate cancer G Civenni, R Vasquez, J Merulla, S Pandit, A Kokanovic, A Timpanaro, ... European Urology Supplements 18 (8), e3109, 2019 | | 2019 |
| SCHWERPUNKTTHEMA: SARKOME M Bernasconi, D Dzhumashev, A Timpanaro, J Rössler ANCER, 129, 2019 | | 2019 |
| Blockade of VEGFR and PD-L1 Inhibits Alveolar Soft-Part Sarcoma G Civenni, R Bosotti, A Timpanaro, R Vàsquez, J Merulla, S Pandit | | |
